Covid-19

Find below the related material about Covid-19

Launch of an ambitious cross-pharma study by the public-private partnership ‘COVIDRIVE’: a multi-country European study to continuously monitor COVID-19 vaccine effectiveness against severe disease

Can partnerships help boost vaccine supply?

EFPIA-Vaccines Europe response on the EU Communication on “Urgent Trade Policy Responses to the COVID-19 crisis"

COVID-19 vaccine makers invite G20 leaders to support the five steps to urgently advance COVID-19 vaccine equity

Five steps to urgently advance COVID-19 vaccine equity

EFPIA/Vaccines Europe statement on IP waiver for COVID-19 vaccines

PRIVACY POLICY

PRIVACY POLICY

© Vaccines Europe - a specialised group
of EFPIA - all rights reserved